173 related articles for article (PubMed ID: 18707194)
1. Advice on drug safety in pregnancy: are there differences between commonly used sources of information?
Frost Widnes SK; Schjøtt J
Drug Saf; 2008; 31(9):799-806. PubMed ID: 18707194
[TBL] [Abstract][Full Text] [Related]
2. Drug use in pregnancy--physicians' evaluation of quality and clinical impact of drug information centres.
Frost Widnes SK; Schjøtt J
Eur J Clin Pharmacol; 2009 Mar; 65(3):303-8. PubMed ID: 19052735
[TBL] [Abstract][Full Text] [Related]
3. Challenges in psychopharmacology: a drug information centre perspective.
Schjøtt J
J Clin Pharm Ther; 2016 Feb; 41(1):4-6. PubMed ID: 26775691
[TBL] [Abstract][Full Text] [Related]
4. Regional drug information service.
Schwarz UI; Stoelben S; Ebert U; Siepmann M; Krappweis J; Kirch W
Int J Clin Pharmacol Ther; 1999 Jun; 37(6):263-8. PubMed ID: 10395116
[TBL] [Abstract][Full Text] [Related]
5. Prescription of hazardous drugs during pregnancy.
Malm H; Martikainen J; Klaukka T; Neuvonen PJ
Drug Saf; 2004; 27(12):899-908. PubMed ID: 15366977
[TBL] [Abstract][Full Text] [Related]
6. Risk classification systems for drug use during pregnancy: are they a reliable source of information?
Addis A; Sharabi S; Bonati M
Drug Saf; 2000 Sep; 23(3):245-53. PubMed ID: 11005706
[TBL] [Abstract][Full Text] [Related]
7. Physicians' Perception of Teratogenic Risk and Confidence in Prescribing Drugs in Pregnancy-Influence of Norwegian Drug Information Centers.
Bakkebø T; Widnes SF; Aamlid SS; Schjøtt J
Clin Ther; 2016 May; 38(5):1102-8. PubMed ID: 26973297
[TBL] [Abstract][Full Text] [Related]
8. Analysis of questions about use of drugs in breastfeeding to Norwegian drug information centres.
Jahnsen JA; Widnes SF; Schjøtt J
Int Breastfeed J; 2018; 13():1. PubMed ID: 29339968
[TBL] [Abstract][Full Text] [Related]
9. Adverse-drug-event data provided by pharmaceutical companies.
Cudny ME; Graham AS
Am J Health Syst Pharm; 2008 Jun; 65(11):1071-5. PubMed ID: 18499882
[TBL] [Abstract][Full Text] [Related]
10. Drug Information Services Today: Current Role and Future Perspectives in Rational Drug Therapy.
Amundstuen Reppe L; Spigset O; Schjøtt J
Clin Ther; 2016 Feb; 38(2):414-21. PubMed ID: 26831829
[TBL] [Abstract][Full Text] [Related]
11. European drug information centres--survey of activities.
Müllerová H; Vlcek J
Pharm World Sci; 1998 Jun; 20(3):131-5. PubMed ID: 9618737
[TBL] [Abstract][Full Text] [Related]
12. Drug information centres and their provision of decision support: The Scandinavian experience.
Schjøtt J; Spigset O
J Clin Pharm Ther; 2019 Jun; 44(3):489-492. PubMed ID: 30710370
[TBL] [Abstract][Full Text] [Related]
13. An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry.
Winther FO; Hole OP; Nitter-Hauge S
Eur J Clin Pharmacol; 2007 Oct; 63(10):909-12. PubMed ID: 17673994
[TBL] [Abstract][Full Text] [Related]
14. Update on the status of 89 drug information centers in the United States.
Rosenberg JM; Schilit S; Nathan JP; Zerilli T; McGuire H
Am J Health Syst Pharm; 2009 Oct; 66(19):1718-22. PubMed ID: 19767377
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist-operated drug information centres in Singapore.
Lim LY; Chui WK
J Clin Pharm Ther; 1999 Feb; 24(1):33-42. PubMed ID: 10319905
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the regional drug information center towards drug safety.
Palaian S; Mishra P; Shankar PR; Bista D; Purwar B
JNMA J Nepal Med Assoc; 2006; 45(161):216-8. PubMed ID: 17160101
[TBL] [Abstract][Full Text] [Related]
17. Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications.
Stockigt JR
Med J Aust; 2007 Jan; 186(2):76-9. PubMed ID: 17223768
[TBL] [Abstract][Full Text] [Related]
18. [Drugs during pregnancy and breastfeeding: new risk categories--antibiotics as a model].
Bertsche T; Haas M; Oberwittler H; Haefeli WE; Walter-Sack I
Dtsch Med Wochenschr; 2006 May; 131(18):1016-22. PubMed ID: 16673226
[TBL] [Abstract][Full Text] [Related]
19. National audit of drug information centers.
Dombrowski SR; Visconti JA
Am J Hosp Pharm; 1985 Apr; 42(4):819-26. PubMed ID: 4014232
[TBL] [Abstract][Full Text] [Related]
20. Survey of drug information centers in the United States-2018.
Grossman S; Nathan JP; Ipema HJ; Ness GL; Tierno HE; Gabay MP; Calip GS
Am J Health Syst Pharm; 2020 Jan; 77(1):33-38. PubMed ID: 31743390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
